Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tracking Triple-negative Breast Cancer Evolution Through Therapy

NCT03077776 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT03077776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03077776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tracking Triple-negative Breast Cancer Evolution Through Therapy
Lead sponsor
UNICANCER
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 14, 2017
Completion date
September 30, 2026
Enrollment
149 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

triple-negative breast neoplasm